Brett Ley1, Thomas Urbania2, Gail Husson3, Eric Vittinghoff4, David R Brush5, Mark D Eisner6, Carlos Iribarren3, Harold R Collard1. 1. 1 Department of Medicine and. 2. 2 Department of Radiology and. 3. 3 Division of Research, Kaiser Permanente Northern California, Oakland, California. 4. 4 Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California. 5. 5 Department of Pulmonary and Critical Care Medicine, Kaiser Permanente, Walnut Creek, California; and. 6. 6 Genentech, Inc., South San Francisco, California.
Abstract
RATIONALE: Population-based studies of idiopathic pulmonary fibrosis (IPF) in the United States have been limited by reliance on diagnostic code-based algorithms that lack clinical validation. OBJECTIVES: To validate a well-accepted International Classification of Diseases, Ninth Revision, code-based algorithm for IPF using patient-level information and to develop a modified algorithm for IPF with enhanced predictive value. METHODS: The traditional IPF algorithm was used to identify potential cases of IPF in the Kaiser Permanente Northern California adult population from 2000 to 2014. Incidence and prevalence were determined overall and by age, sex, and race/ethnicity. A validation subset of cases (n = 150) underwent expert medical record and chest computed tomography review. A modified IPF algorithm was then derived and validated to optimize positive predictive value. RESULTS: From 2000 to 2014, the traditional IPF algorithm identified 2,608 cases among 5,389,627 at-risk adults in the Kaiser Permanente Northern California population. Annual incidence was 6.8/100,000 person-years (95% confidence interval [CI], 6.1-7.7) and was higher in patients with older age, male sex, and white race. The positive predictive value of the IPF algorithm was only 42.2% (95% CI, 30.6 to 54.6%); sensitivity was 55.6% (95% CI, 21.2 to 86.3%). The corrected incidence was estimated at 5.6/100,000 person-years (95% CI, 2.6-10.3). A modified IPF algorithm had improved positive predictive value but reduced sensitivity compared with the traditional algorithm. CONCLUSIONS: A well-accepted International Classification of Diseases, Ninth Revision, code-based IPF algorithm performs poorly, falsely classifying many non-IPF cases as IPF and missing a substantial proportion of IPF cases. A modification of the IPF algorithm may be useful for future population-based studies of IPF.
RATIONALE: Population-based studies of idiopathic pulmonary fibrosis (IPF) in the United States have been limited by reliance on diagnostic code-based algorithms that lack clinical validation. OBJECTIVES: To validate a well-accepted International Classification of Diseases, Ninth Revision, code-based algorithm for IPF using patient-level information and to develop a modified algorithm for IPF with enhanced predictive value. METHODS: The traditional IPF algorithm was used to identify potential cases of IPF in the Kaiser Permanente Northern California adult population from 2000 to 2014. Incidence and prevalence were determined overall and by age, sex, and race/ethnicity. A validation subset of cases (n = 150) underwent expert medical record and chest computed tomography review. A modified IPF algorithm was then derived and validated to optimize positive predictive value. RESULTS: From 2000 to 2014, the traditional IPF algorithm identified 2,608 cases among 5,389,627 at-risk adults in the Kaiser Permanente Northern California population. Annual incidence was 6.8/100,000 person-years (95% confidence interval [CI], 6.1-7.7) and was higher in patients with older age, male sex, and white race. The positive predictive value of the IPF algorithm was only 42.2% (95% CI, 30.6 to 54.6%); sensitivity was 55.6% (95% CI, 21.2 to 86.3%). The corrected incidence was estimated at 5.6/100,000 person-years (95% CI, 2.6-10.3). A modified IPF algorithm had improved positive predictive value but reduced sensitivity compared with the traditional algorithm. CONCLUSIONS: A well-accepted International Classification of Diseases, Ninth Revision, code-based IPF algorithm performs poorly, falsely classifying many non-IPF cases as IPF and missing a substantial proportion of IPF cases. A modification of the IPF algorithm may be useful for future population-based studies of IPF.
Authors: Ganesh Raghu; Harold R Collard; Jim J Egan; Fernando J Martinez; Juergen Behr; Kevin K Brown; Thomas V Colby; Jean-François Cordier; Kevin R Flaherty; Joseph A Lasky; David A Lynch; Jay H Ryu; Jeffrey J Swigris; Athol U Wells; Julio Ancochea; Demosthenes Bouros; Carlos Carvalho; Ulrich Costabel; Masahito Ebina; David M Hansell; Takeshi Johkoh; Dong Soon Kim; Talmadge E King; Yasuhiro Kondoh; Jeffrey Myers; Nestor L Müller; Andrew G Nicholson; Luca Richeldi; Moisés Selman; Rosalind F Dudden; Barbara S Griss; Shandra L Protzko; Holger J Schünemann Journal: Am J Respir Crit Care Med Date: 2011-03-15 Impact factor: 21.405
Authors: Ganesh Raghu; Derek Weycker; John Edelsberg; Williamson Z Bradford; Gerry Oster Journal: Am J Respir Crit Care Med Date: 2006-06-29 Impact factor: 21.405
Authors: Ganesh Raghu; David Lynch; J David Godwin; Richard Webb; Thomas V Colby; Kevin O Leslie; Juergen Behr; Kevin K Brown; James J Egan; Kevin R Flaherty; Fernando J Martinez; Athol U Wells; Lixin Shao; Huafeng Zhou; Patricia S Pedersen; Rohit Sood; A Bruce Montgomery; Thomas G O'Riordan Journal: Lancet Respir Med Date: 2014-02-18 Impact factor: 30.700
Authors: Kunihiro Yagihashi; Jason Huckleberry; Thomas V Colby; Henry D Tazelaar; Jordan Zach; Baskaran Sundaram; Sudhakar Pipavath; Marvin I Schwarz; David A Lynch Journal: Eur Respir J Date: 2016-02-25 Impact factor: 16.671
Authors: Christopher J Ryerson; Thomas H Urbania; Luca Richeldi; Joshua J Mooney; Joyce S Lee; Kirk D Jones; Brett M Elicker; Laura L Koth; Talmadge E King; Paul J Wolters; Harold R Collard Journal: Eur Respir J Date: 2012-12-06 Impact factor: 16.671
Authors: Evans R Fernández Pérez; Craig E Daniels; Darrell R Schroeder; Jennifer St Sauver; Thomas E Hartman; Brian J Bartholmai; Eunhee S Yi; Jay H Ryu Journal: Chest Date: 2009-09-11 Impact factor: 9.410
Authors: Bryant R England; Punyasha Roul; Tina D Mahajan; Namrata Singh; Fang Yu; Harlan Sayles; Grant W Cannon; Brian C Sauer; Joshua F Baker; Jeffrey R Curtis; Ted R Mikuls Journal: Arthritis Care Res (Hoboken) Date: 2020-10 Impact factor: 4.794
Authors: Stacey-Ann Whittaker Brown; Maria Padilla; Grace Mhango; Emanuela Taioli; Charles Powell; Juan Wisnivesky Journal: Ann Am Thorac Soc Date: 2019-08
Authors: Dmytro Onishchenko; Robert J Marlowe; Che G Ngufor; Louis J Faust; Andrew H Limper; Gary M Hunninghake; Fernando J Martinez; Ishanu Chattopadhyay Journal: Nat Med Date: 2022-09-29 Impact factor: 87.241
Authors: Ayodeji Adegunsoye; Justin M Oldham; Shashi K Bellam; Jonathan H Chung; Paul A Chung; Kathleen M Biblowitz; Steven Montner; Cathryn Lee; Scully Hsu; Aliya N Husain; Rekha Vij; Gokhan Mutlu; Imre Noth; Matthew M Churpek; Mary E Strek Journal: Eur Respir J Date: 2018-06-14 Impact factor: 16.671
Authors: Erica Farrand; Carlos Iribarren; Eric Vittinghoff; Tory Levine-Hall; Brett Ley; George Minowada; Harold R Collard Journal: Chest Date: 2020-07-24 Impact factor: 9.410
Authors: Bhavika Kaul; Joyce S Lee; Ning Zhang; Eric Vittinghoff; Kathleen Sarmiento; Harold R Collard; Mary A Whooley Journal: Ann Am Thorac Soc Date: 2022-02
Authors: Toby M Maher; Elisabeth Bendstrup; Louis Dron; Jonathan Langley; Gerald Smith; Javaria Mona Khalid; Haridarshan Patel; Michael Kreuter Journal: Respir Res Date: 2021-07-07